doubleantibioticointment 500 [USP'U]/g
bacitracin zinc, polymyxin B sulfate · OINTMENT · Trifecta Pharmaceuticals USA LLC
doubleantibioticointment is a ointment containing bacitracin zinc, polymyxin b sulfate at 500 [USP'U]/g, taken topical. Manufactured by Trifecta Pharmaceuticals USA LLC.
Key Facts
- Brand Name
- doubleantibioticointment
- Generic Name
- bacitracin zinc, polymyxin B sulfate
- NDC Code (Product)
69396-029- Manufacturer
- Trifecta Pharmaceuticals USA LLC
- Strength
- 500 [USP'U]/g
- Dosage Form
- OINTMENT
- Route
- TOPICAL
- Marketing Status
- Application #
- M004
- Marketing Start
- 05/04/2017
Recall History
No Recall HistoryFrequently Asked Questions
What is doubleantibioticointment used for?
doubleantibioticointment contains bacitracin zinc, polymyxin B sulfate. It is a ointment taken topical. Consult your doctor for specific uses.
Is doubleantibioticointment a controlled substance?
doubleantibioticointment is not classified as a controlled substance by the DEA.
What is the generic name for doubleantibioticointment?
The generic name for doubleantibioticointment is bacitracin zinc, polymyxin B sulfate. There are 11 other brand versions of bacitracin zinc, polymyxin B sulfate.
What is the NDC code for doubleantibioticointment 500 [USP'U]/g?
The NDC (National Drug Code) for doubleantibioticointment 500 [USP'U]/g is 69396-029, listed by Trifecta Pharmaceuticals USA LLC.
Other Bacitracin Brands
See all →- Drs. pharmacy triple antibiotic plus lidocaine500 [USP'U]/g80489-912
- Thompson Triple Antibiotic400 [USP'U]/g73408-935
- Cuadriderma500 [iU]/g58988-1170
- Sheffield Triple Antibiotic400 [USP'U]/g11527-162
- POLVO DE SULFA FIRST AID ANTIBIOTIC500 [USP'U]/g48201-105
- Polvos de Sulpha First Aid Antibiotic500 [USP'U]/g53145-304
- Bacitracin Zinc, Polymyxin B Sulfate, and Neomycin Sulfate400 [iU]/g0404-0171
- Sheffield Triple Antibiotic Plus Pain Relief500 [USP'U]/g11527-161
- Antibiotic500 [iU]/g51316-044
- Water-Jel 3-in-1 Antibiotic417.8 [iU]/g59898-740
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)